The Raleigh office of Carolina Nonsurgical Orthopedics, a non-surgical practice offering fat-derived cell therapy and high-dose platelet injections for arthritis and sports injuries.
This entry covers the Raleigh office of Carolina Nonsurgical Orthopedics, at 7200 Creedmoor Road, one of two offices the practice runs alongside Cary. According to the site the practice was established in 2013 and treats joint and soft tissue problems without surgery. Its physicians are non-surgical orthopaedic specialists rather than surgeons, and the site states that most major insurances are accepted — which in this sector is unusual, although it is likely to apply to conventional care rather than to cell treatments.
The practice's principal cell treatment is what it calls microfragmented adipose tissue therapy, usually abbreviated to MFAT. The site states that the fat is obtained through a minimally invasive mini-liposuction and is then concentrated and mechanically broken down rather than grown in a laboratory, so the material is autologous (from the patient's own body). The preparation is described as containing mesenchymal stem cells together with growth factors, cytokines and extracellular matrix components, and the site explains that it cannot say how many stem cells are present because United States regulation restricts processing to minimal manipulation and does not permit culturing. Alongside this the practice offers platelet rich plasma (PRP, prepared from the patient's own blood), including formulations it markets as high-dose and as an enhanced version combining plasma proteins with hyaluronic acid.
The site mixes promotional claims with unusually frank caveats. It refers to high success rates, to studies supporting relief for up to two to three years, and to creating a cellular cushion for joints; a reader should treat these as the clinic's own marketing rather than settled evidence. But the same page states that there are no large studies confirming that these cells regrow cartilage, and that the practice will never promise a patient will avoid surgery forever. Those admissions are worth weighing when comparing providers, most of which say nothing of the kind.
Besides cell and platelet work, the practice offers image-guided corticosteroid injections, non-surgical sports medicine, post-surgical pain management, lavage for calcific tendonitis, cyst drainage, hydrodilatation for frozen shoulder, shockwave therapy, and on-site X-ray and diagnostic ultrasound. The fat-derived cell therapy is described as used mainly for knee arthritis and bone-on-bone knee pain, and sometimes for the hip and shoulder or for large tendon tears.
The site lists joint and soft tissue problems by diagnosis and by body region, and is specific about which ones the fat-derived cell therapy is used for.
The site states that its cell treatment uses the patient's own fat, taken by mini-liposuction and then concentrated and mechanically broken down rather than cultured, and that the preparation contains mesenchymal stem cells along with growth factors, cytokines and extracellular matrix.
Two non-surgical orthopaedic physicians and a physician associate are named on the practice's team page; neither physician is a surgeon.
The Raleigh office is at 7200 Creedmoor Road, Suite 102, Raleigh, North Carolina 27613, one of two offices alongside Cary. It is presented as an outpatient clinic with on-site X-ray and diagnostic ultrasound, where injections and the mini-liposuction fat harvest are carried out in the clinic rather than in a hospital theatre, and where fat is processed mechanically the same day rather than sent away for culture. Clinical support staff named on the site include certified medical assistants, one with a phlebotomy certification. No accreditation or inspection information is published and no languages are mentioned.
The site does not publish prices for the fat-derived cell therapy or for platelet injections. It states that most major insurances are accepted, which is likely to cover conventional consultations, imaging and steroid injections rather than cell treatment, since such treatment is generally self-funded in the United States. A prospective patient should ask for a written price for the cell therapy specifically and confirm separately what insurance will pay.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.